Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Journey Medical Corp (DERM:NASDAQ), powered by AI.
Journey Medical Corp is currently trading at $6.11. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Journey Medical Corp on Alpha Lenz.
View Journey Medical Corp's valuation metrics on Alpha Lenz.
“Journey Medical Corp's ROE is -44.0%. Explore profitability and growth together.”
Ask for details →Journey Medical Corp is an esteemed biopharmaceutical company focused on the dermatological sector. Its primary function is to develop and commercialize innovative pharmaceutical products that address the unmet medical needs in dermatology. Journey Medical Corp's portfolio includes a wide range of dermatological products designed to treat various conditions, including acne, rosacea, and other skin disorders. The company's emphasis on dermatology allows it to significantly impact the healthcare industry by providing critical treatments that enhance patient care and outcomes. As a player in the biopharmaceutical market, Journey Medical Corp contributes to advancing medical research and development, particularly in skin care solutions. This focus not only enhances its importance in the healthcare sector but also emphasizes the growing need for specialized therapies in dermatology, underscoring its role in improving the quality of life for patients suffering from chronic skin conditions.
“Journey Medical Corp's ROE is -44.0%. Explore profitability and growth together.”
Ask for details →Journey Medical Corp (ticker: DERM) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 41 employees.
The current price is $6.11 with a P/E ratio of -x and P/B of -x.
ROE is -44.03% and operating margin is -13.21%. Annual revenue is $62M.